Pharmaprojects, Trialtrove, Citeline, TrialSc...

Tap into UK and Ireland drug development and trial activity trends

25 Aug 2022

Download your free infographic for a snapshot view of UK vs. EU4 clinical landscape

What Does The Pharma Industry Want From CROs?

15 Jun 2022

Get exclusive insights into what senior decision makers from small to large biotech and pharma companies want from contract research organizations.

Pharma Intelligence Apps

What Does The Pharma Industry Want From CDMOs?

13 May 2022

Based on a survey to over 100 of pharma’s senior decision makers, find out what organizations really want from CDMOs.

Scrip

Scrip Asia 100

20 Sep 2021

The highly anticipated Scrip Asia 100 is back, and there are a limited number of opportunities for you to be a part of it. Don’t miss your chance to connect to APAC market leaders with a high-profile sponsorship of this essential annual financial performance ranking of pharma companies headquartered in the APAC region.

In Vivo

How To Obtain Effective Relief When A Global Pandemic Disrupts Your Supply Chain

By Dorothee Schramm and Katie von der Weid 27 Nov 2020

The COVID-19 pandemic is disrupting global supply chains and companies need effective tools to manage the related contract disputes. Sidley Austin partner Dorothee Schramm and senior associate Katie von der Weid, both specialized in international commercial disputes, provide tips to help companies manage the situation.

In Vivo

Bayer US Pharmaceuticals' Sebastian Guth: Designs On A New Decade

By William Looney 27 Nov 2020

Bayer’s ambitious campaign to reposition itself as a global leader in two complementary fields – health and nutrition – will face its toughest test in the US, with its highly litigious approach to product liability and a tendency to target pharmaceuticals as the source of the health system’s affordability and access problems.

Biomedtracker

Informa Pharma Intelligence and QLS Advisors Partner to Pilot Predictive Analysis Tool for Clinical Trials

24 Nov 2020

Partnership will help inform key decisions with new drug-level probability of approval scores powered by QLS and incorporated into Informa Pharma Intelligence’s Biomedtracker

Scrip

Slow And Steady: Merck Advances COVID-19 Antiviral, Vaccine Programs

By Mandy Jackson 17 Nov 2020

Merck’s third quarter beat analyst consensus and the company raised its guidance. The COVID-19-battered vaccines business began to improve but Gardasil’s recovery was slower than expected.

Scrip

Scrip Asia 100 Report Extract

03 Nov 2020

In a year epitomized by a global pandemic, the depth and implications of pharma activity across Asia has been staggering. Gain unique insight into the companies, products and themes leading the industry when you download the Scrip Asia 100 Report, written by our experienced on-the-ground journalists throughout this vast region.